ARCHIVES

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

FTE Shortage Hurting Cancer and AIDS Research, Advisors Told; NCI Seeks Major Share Of New Slots

October 14, 1988

In Brief: Upton Okays Laetrile Clinical Trials, To Seek Protocols From Clinicians For IND Request

October 6, 1978

PDQ Out of Business Of Setting Guidelines For Cancer Screening

September 17, 1993

Clinical Trials Approved by NCI CTEP Last Month

August 26, 2011

Wittes, Group Chairmen Agree On Payment Per Case, Other Methods To Increase Patient Accrual

August 21, 1987

New Publications

January 20, 1989